Skip to main content
Top
Published in: Supportive Care in Cancer 6/2020

01-06-2020 | Cytostatic Therapy | Original Article

Objectively measured physical activity during chemotherapy in colon cancer patients

Authors: Hyuna Park, Minkyu Jung, Min Jae Kim, Jihee Min, Choong-Kun Lee, Sang Joon Shin, Seung-Hoon Beom, Joong Bae Ahn, Justin Y. Jeon

Published in: Supportive Care in Cancer | Issue 6/2020

Login to get access

Abstract

Purpose

Although adjuvant chemotherapy can have an impact on physical activity (PA), PA level has not been studied in patients with stage II–III colon cancer. This study investigated PA levels during and between chemotherapy cycles.

Methods

We objectively measured PA levels for 2 weeks during the 2nd and 11th chemotherapy cycles. In addition, self-reported PA levels were assessed before chemotherapy initiation, during 2nd, 6th, and 12th chemotherapy cycles. This study included 22 men and 33 women with stage II–III colon cancer patients (57 ± 9 years).

Results

Before the initiation of chemotherapy, most cancer patients were minimally active. Compared with the 1st week of chemotherapy, moderate- and light-intensity PA levels significantly increased during the 2nd week of chemotherapy. Patients increased moderate- and light-intensity PA from 217.4 to 290.3 min per week and from 585.7 to 657.8 min per week, respectively (p < 0.01). PA levels did not show any difference between the 2nd and 12th cycles when objectively measured, or between baseline and 2nd, 6th, and 12th cycles when self-reported.

Conclusion

PA levels during chemotherapy cycles are initially low, and then increase towards the end of the cycle; however, PA levels do not change between chemotherapy cycles. Future work with broader and larger samples size is recommended.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ahn KY, Hur H, Kim DH, Min J, Jeong DH, Chu SH, Lee JW, Ligibel JA, Meyerhardt JA, Jones LW, Jeon JY, Kim NK (2013) The effects of inpatient exercise therapy on the length of hospital stay in stages I-III colon cancer patients: randomized controlled trial. Int J Color Dis 28:643–651CrossRef Ahn KY, Hur H, Kim DH, Min J, Jeong DH, Chu SH, Lee JW, Ligibel JA, Meyerhardt JA, Jones LW, Jeon JY, Kim NK (2013) The effects of inpatient exercise therapy on the length of hospital stay in stages I-III colon cancer patients: randomized controlled trial. Int J Color Dis 28:643–651CrossRef
2.
go back to reference Ainsworth BE, Bassett DR Jr, Strath SJ, Swartz AM, O’Brien WL, Thompson RW, Jones DA, Macera CA, Kimsey CD (2000) Comparison of three methods for measuring the time spent in physical activity. Med Sci Sports Exerc 32:S457–S464CrossRef Ainsworth BE, Bassett DR Jr, Strath SJ, Swartz AM, O’Brien WL, Thompson RW, Jones DA, Macera CA, Kimsey CD (2000) Comparison of three methods for measuring the time spent in physical activity. Med Sci Sports Exerc 32:S457–S464CrossRef
3.
go back to reference Bellemare S, Heyen F, Martin G, Dube S (1998) Assessment of the quality of life during adjuvant chemotherapy of colorectal cancer. Ann Chir 52:711–715PubMed Bellemare S, Heyen F, Martin G, Dube S (1998) Assessment of the quality of life during adjuvant chemotherapy of colorectal cancer. Ann Chir 52:711–715PubMed
4.
go back to reference Benson AB 3rd, Bekaii-Saab T, Chan E, Chen YJ, Choti MA, Cooper HS, Engstrom PF, Enzinger PC, Fakih MG, Fenton MJ, Fuchs CS, Grem JL, Hunt S, Kamel A, Leong LA, Lin E, May KS, Mulcahy MF, Murphy K, Rohren E, Ryan DP, Saltz L, Sharma S, Shibata D, Skibber JM, Small W Jr, Sofocleous CT, Venook AP, Willett CG, Gregory KM, Freedman-Cass DA, National Comprehensive Cancer N (2013) Localized colon cancer, version 3.2013: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw 11:519–528CrossRef Benson AB 3rd, Bekaii-Saab T, Chan E, Chen YJ, Choti MA, Cooper HS, Engstrom PF, Enzinger PC, Fakih MG, Fenton MJ, Fuchs CS, Grem JL, Hunt S, Kamel A, Leong LA, Lin E, May KS, Mulcahy MF, Murphy K, Rohren E, Ryan DP, Saltz L, Sharma S, Shibata D, Skibber JM, Small W Jr, Sofocleous CT, Venook AP, Willett CG, Gregory KM, Freedman-Cass DA, National Comprehensive Cancer N (2013) Localized colon cancer, version 3.2013: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw 11:519–528CrossRef
5.
go back to reference Berger AM, Grem JL, Visovsky C, Marunda HA, Yurkovich JM (2010) Fatigue and other variables during adjuvant chemotherapy for colon and rectal cancer. Oncol Nurs Forum 37:E359–E369CrossRef Berger AM, Grem JL, Visovsky C, Marunda HA, Yurkovich JM (2010) Fatigue and other variables during adjuvant chemotherapy for colon and rectal cancer. Oncol Nurs Forum 37:E359–E369CrossRef
6.
go back to reference Chung JY, Lee DH, Park JH, Lee MK, Kang DW, Min J, Kim DI, Jeong DH, Kim NK, Meyerhardt JA, Jones LW, Jeon JY (2013) Patterns of physical activity participation across the cancer trajectory in colorectal cancer survivors. Support Care Cancer 21:1605–1612CrossRef Chung JY, Lee DH, Park JH, Lee MK, Kang DW, Min J, Kim DI, Jeong DH, Kim NK, Meyerhardt JA, Jones LW, Jeon JY (2013) Patterns of physical activity participation across the cancer trajectory in colorectal cancer survivors. Support Care Cancer 21:1605–1612CrossRef
7.
go back to reference Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P (2003) International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35:1381–1395CrossRef Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P (2003) International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35:1381–1395CrossRef
8.
go back to reference Engstrom PF, Arnoletti JP, Benson AB 3rd, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J Jr, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Lin E, Mulcahy MF, Rao S, Ryan DP, Saltz L, Shibata D, Skibber JM, Sofocleous C, Thomas J, Venook AP, Willett C, National Comprehensive Cancer N (2009) NCCN clinical practice guidelines in oncology: colon cancer. J Natl Compr Canc Netw 7:778–831CrossRef Engstrom PF, Arnoletti JP, Benson AB 3rd, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J Jr, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Lin E, Mulcahy MF, Rao S, Ryan DP, Saltz L, Shibata D, Skibber JM, Sofocleous C, Thomas J, Venook AP, Willett C, National Comprehensive Cancer N (2009) NCCN clinical practice guidelines in oncology: colon cancer. J Natl Compr Canc Netw 7:778–831CrossRef
9.
go back to reference Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386CrossRef Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386CrossRef
10.
go back to reference Freedson PS, Melanson E, Sirard J (1998) Calibration of the Computer Science and Applications, Inc. accelerometer. Med Sci Sports Exerc 30:777–781CrossRef Freedson PS, Melanson E, Sirard J (1998) Calibration of the Computer Science and Applications, Inc. accelerometer. Med Sci Sports Exerc 30:777–781CrossRef
11.
go back to reference Jung KW, Won YJ, Kong HJ, Oh CM, Seo HG, Lee JS (2013) Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010. Cancer Res Treat 45:1–14CrossRef Jung KW, Won YJ, Kong HJ, Oh CM, Seo HG, Lee JS (2013) Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010. Cancer Res Treat 45:1–14CrossRef
12.
go back to reference Kleckner IR, Dunne RF, Asare M, Cole C, Fleming F, Fung C, Lin PJ, Mustian KM (2018) Exercise for toxicity management in cancer-a narrative review. Oncol Hematol Rev 14:28–37PubMedPubMedCentral Kleckner IR, Dunne RF, Asare M, Cole C, Fleming F, Fung C, Lin PJ, Mustian KM (2018) Exercise for toxicity management in cancer-a narrative review. Oncol Hematol Rev 14:28–37PubMedPubMedCentral
13.
go back to reference Lin KY, Shun SC, Lai YH, Liang JT, Tsauo JY (2013) Comparison of the effects of a supervised exercise program and usual care in patients with colorectal cancer undergoing chemotherapy. Cancer Nurs Lin KY, Shun SC, Lai YH, Liang JT, Tsauo JY (2013) Comparison of the effects of a supervised exercise program and usual care in patients with colorectal cancer undergoing chemotherapy. Cancer Nurs
14.
go back to reference Peace K, Perez D, Beckers M, Freeman J, Tripp G (2003) The effect of adjuvant chemotherapy on quality of life of patients with colorectal cancer. Psycho-oncology 12:S153–S153CrossRef Peace K, Perez D, Beckers M, Freeman J, Tripp G (2003) The effect of adjuvant chemotherapy on quality of life of patients with colorectal cancer. Psycho-oncology 12:S153–S153CrossRef
15.
go back to reference Piggin L, Dwek MR, Propper D, Machesney M, Rixon L, Newman S, Hirani S, Hurt C (2017) Perceived cognitive impairment and quality of life during adjuvant chemotherapy for colorectal cancer: a preliminary report from a longitudinal study. Psycho-oncology 26:8–8 Piggin L, Dwek MR, Propper D, Machesney M, Rixon L, Newman S, Hirani S, Hurt C (2017) Perceived cognitive impairment and quality of life during adjuvant chemotherapy for colorectal cancer: a preliminary report from a longitudinal study. Psycho-oncology 26:8–8
16.
go back to reference Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018 CA: a cancer. J Clin 68:7–30 Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018 CA: a cancer. J Clin 68:7–30
17.
go back to reference Tsuji Y, Baba H, Takeda K, Kobayashi M, Oki E, Gotoh M, Yoshida K, Shimokawa M, Kakeji Y, Aiba K (2017) Chemotherapy-induced nausea and vomiting (CINV) in 190 colorectal cancer patients: a prospective registration study by the CINV study group of Japan. Expert Opin Pharmacother 18:753–758CrossRef Tsuji Y, Baba H, Takeda K, Kobayashi M, Oki E, Gotoh M, Yoshida K, Shimokawa M, Kakeji Y, Aiba K (2017) Chemotherapy-induced nausea and vomiting (CINV) in 190 colorectal cancer patients: a prospective registration study by the CINV study group of Japan. Expert Opin Pharmacother 18:753–758CrossRef
18.
go back to reference van Rooijen SJ, Engelen MA, Scheede-Bergdahl C, Carli F, Roumen RMH, Slooter GD, Schep G (2018) Systematic review of exercise training in colorectal cancer patients during treatment. Scand J Med Sci Sports 28:360–370CrossRef van Rooijen SJ, Engelen MA, Scheede-Bergdahl C, Carli F, Roumen RMH, Slooter GD, Schep G (2018) Systematic review of exercise training in colorectal cancer patients during treatment. Scand J Med Sci Sports 28:360–370CrossRef
19.
go back to reference Van Vulpen JK, Velthuis MJ, Steins Bisschop CN, Travier N, Van Den Buijs BJ, Backx FJ, Los M, Erdkamp FL, Bloemendal HJ, Koopman M, De Roos MA, Verhaar MJ, Ten Bokkel-Huinink D, Van Der Wall E, Peeters PH, May AM (2016) Effects of an exercise program in colon cancer patients undergoing chemotherapy. Med Sci Sports Exerc 48:767–775CrossRef Van Vulpen JK, Velthuis MJ, Steins Bisschop CN, Travier N, Van Den Buijs BJ, Backx FJ, Los M, Erdkamp FL, Bloemendal HJ, Koopman M, De Roos MA, Verhaar MJ, Ten Bokkel-Huinink D, Van Der Wall E, Peeters PH, May AM (2016) Effects of an exercise program in colon cancer patients undergoing chemotherapy. Med Sci Sports Exerc 48:767–775CrossRef
20.
go back to reference van Waart H, Stuiver MM, van Harten WH, Geleijn E, Kieffer JM, Buffart LM, de Maaker-Berkhof M, Boven E, Schrama J, Geenen MM, Meerum Terwogt JM, van Bochove A, Lustig V, van den Heiligenberg SM, Smorenburg CH, Hellendoorn-van Vreeswijk JA, Sonke GS, Aaronson NK (2015) Effect of low-intensity physical activity and moderate- to high-intensity physical exercise during adjuvant chemotherapy on physical fitness, fatigue, and chemotherapy completion rates: results of the PACES randomized clinical trial. J Clin Oncol 33:1918–1927CrossRef van Waart H, Stuiver MM, van Harten WH, Geleijn E, Kieffer JM, Buffart LM, de Maaker-Berkhof M, Boven E, Schrama J, Geenen MM, Meerum Terwogt JM, van Bochove A, Lustig V, van den Heiligenberg SM, Smorenburg CH, Hellendoorn-van Vreeswijk JA, Sonke GS, Aaronson NK (2015) Effect of low-intensity physical activity and moderate- to high-intensity physical exercise during adjuvant chemotherapy on physical fitness, fatigue, and chemotherapy completion rates: results of the PACES randomized clinical trial. J Clin Oncol 33:1918–1927CrossRef
21.
go back to reference Yothers G, O’Connell MJ, Allegra CJ, Kuebler JP, Colangelo LH, Petrelli NJ, Wolmark N (2011) Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses. J Clin Oncol 29:3768–3774CrossRef Yothers G, O’Connell MJ, Allegra CJ, Kuebler JP, Colangelo LH, Petrelli NJ, Wolmark N (2011) Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses. J Clin Oncol 29:3768–3774CrossRef
Metadata
Title
Objectively measured physical activity during chemotherapy in colon cancer patients
Authors
Hyuna Park
Minkyu Jung
Min Jae Kim
Jihee Min
Choong-Kun Lee
Sang Joon Shin
Seung-Hoon Beom
Joong Bae Ahn
Justin Y. Jeon
Publication date
01-06-2020
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 6/2020
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-019-05049-9

Other articles of this Issue 6/2020

Supportive Care in Cancer 6/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine